1. Copeland, J. G., Smith, R. G., Arabia, F. A., Nolan, P. E., Sethi, G. K., Tsau, P. H., McClellan, D., & Slepian, M. J. (2004). Cardiac replacement with a total artificial heart as a bridge to transplantation. The New England Journal of Medicine, 351(9), 859–867. doi: 10.1056/NEJMoa040186 .
2. Slepian, M. J., Smith, R. G., & Copeland, J. C. (2006). The SynCardia CardioWest total artificial heart. In K. L. Baughman & W. A. Baumgartner (Eds.), Treatment of advanced heart disease, vol 56. Fundamental and clinical cardiology series (pp. 473–490). New York: Taylor & Francis Group.
3. Frazier, O. H., & Cohn, W. E. (2012). Continuous-flow total heart replacement device implanted in a 55-year-old man with end-stage heart failure and severe amyloidosis. Texas Heart Institute journal / from the Texas Heart Institute of St Luke’s Episcopal Hospital, Texas Children’s Hospital, 39(4), 542–546.
4. Slepian, M. J., Alemu, Y., Girdhar, G., Soares, J. S., Smith, R. G., Einav, S., & Bluestein, D. (2013). The Syncardia total artificial heart: in vivo, in vitro, and computational modeling studies. Journal of Biomechanics, 46(2), 266–275. doi: 10.1016/j.jbiomech.2012.11.032 .
5. Platis, A., & Larson, D. F. (2009). CardioWest temporary total artificial heart. Perfusion, 24(5), 341–346. doi: 10.1177/0267659109351330 .